Fri.Sep 23, 2022

article thumbnail

Recognizing National Sickle Cell Awareness Month

PhRMA

September is National Sickle Cell Awareness Month and a time for us to underscore the biopharmaceutical industry’s ongoing commitment to improve the lives of patients, families and communities affected by sickle cell disease.

276
276
article thumbnail

2022-2023 Influenza Season Looks to Be Severe

Pharmacy Times

Outpatient Treatment Is Primarily Based on Patient-Specific Factors, Whereas Oseltamivir Remains the Therapy of Choice for Inpatient Settings.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Partnerships are driving global COVID-19 treatment access

PhRMA

Through the constant efforts of U.S. innovators and their global partners, COVID-19 treatments have continued to be distributed to patients around the world — changing the pandemic’s treatment landscape and the trajectory of the virus’ impact. This is in no small part due to the more than 140 collaborations for COVID-19 treatments that have been signed since the start of the pandemic, as reported to PhRMA by global data provider Airfinity.

Vaccines 147
article thumbnail

The Pharmacist’s Role: Opioid-related Risks With a Psychiatric Drug

Pharmacy Times

Pharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.

132
132
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

5 Smarter Purchasing Trends to Drive Savings and Enhance Operations

Drug Topics

Thousands of pharmacy professionals use SureCost every day to save. We examined their anonymized data to uncover five unique savings opportunities. Now, we've summarized these findings so that you can download our report.

98
article thumbnail

Study Results Show Link Between Excess Weight and Risk of COVID-19, Lasting Disease

Pharmacy Times

Analyses of more than 30,000 adults in the United Kingdom from 9 prospective cohort studies finds a high pre-pandemic BMI was associated with the infection.

123
123

More Trending

article thumbnail

Pfizer to deliver up to six million courses of Paxlovid to Global Fund

Pharmaceutical Technology

Pfizer has entered an agreement with Global Fund to deliver up to six million courses of its oral therapy, Paxlovid (nirmatrelvir tablets and ritonavir tablets), under the Covid-19 Response Mechanism (C19RM). The C19RM has been the main channel to support low- and middle-income nations in procuring Covid-19 therapies, personal protective equipment, tests and vital elements to bolster health systems.

111
111
article thumbnail

FreeStyle Libre System Reduces Diabetes-Related Hospitalizations for Patients with Type 2 Diabetes

Pharmacy Times

The study also showed sustained reductions in hospitalizations over a 2-year period of FreeStyle Libre system use.

Hospitals 123
article thumbnail

Surgeons often take a fifth of the lungs to remove a small tumor. There may be a better way.

STAT

Claudia Donohue was on the operating table first thing in the morning. It wasn’t where she wanted to end up when she first learned she had lung cancer. When she saw the constellation of white dots on her chest scan, she figured the last 59 years of smoking cigarettes had finally caught up to her. Plus, she’d already had cancer once before, in her bladder.

96
article thumbnail

CDC Awards Funding to Assist in Improvement of HIV Testing, Awareness

Pharmacy Times

Program will start to distribute a free HIV self-test to people who enroll by early 2023.

132
132
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Shakeup with Optum’s health data licensing sparks an outcry among scientists

STAT

A move by Optum to change longstanding practices for licensing data to academic institutions has sparked an outcry among researchers, who argue the move will make accessing data so costly and difficult that universities will scale back their research programs. Optum notified users that they now must access insurance claims data through an enclave hosted by another unit of the company.

article thumbnail

Costco reports strong Q4, fiscal year 2022 results

Drug Store News

Costco reported that net sales for the quarter increased 15.2%, to $70.76 billion, from $61.44 billion last year, while net sales for the fiscal year increased 16%, to $222.73 billion, from $192.05 billion last year.

98
article thumbnail

Rivus raises $132m to advance clinical development of obesity treatment

Pharmaceutical Technology

Rivus Pharmaceuticals has raised $132m in a Series B funding round to clinically advance its lead candidate, HU6, for the treatment of obesity and cardio-metabolic disorders. RA Capital Management led the financing round, which also saw participation from Bain Capital Life Sciences and BB Biotech. Existing investors of the company, including Longitude Capital, Medicxi and RxCapital, also took part in the round.

96
article thumbnail

Senator Roger Marshall Seeks to End COVID-19 Pandemic National Emergency

Drug Topics

Congress could overrule presidential declaration, but White House threatened veto of similar measure in March.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Inflation caused another big drop in net drug prices, analysis finds

STAT

Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name drugmakers increased their wholesale prices by 4.9% in the second quarter this year, up slightly from 4.4% a year earlier. But when accounting for inflation, wholesale prices fell by 3.7%, and inflationary pressures are likely to push wholesale prices still higher.

83
article thumbnail

Pharmacy Legal Issues

DiversifyRx

When you have owned a pharmacy long enough, pharmacy legal issues are bound to happen to you. . Types of Pharmacy Legal Issues for Pharmacy Owners. Legal troubles can fall from many angles for pharmacy owners. Here’s a short list: Employment lawsuits Board of Pharmacy actions PBM audits PBM contracts Pharmacist dispensing activities Patient prescription fraud Landlord issues Former employer issues Employee theft Robbery.

article thumbnail

5 Ways Your Pharmacy Can Participate in National Pain Awareness Month

Digital Pharmacist

Pharmacies play a pivotal role in educating patients and caregivers about pain and the medications used to treat it. With September being National Pain Awareness Month, we thought this was the perfect time to discuss this initiative and how we can work together to bring awareness to it. American adults have or have had chronic pain. American adults have or have had high-impact chronic pain.

article thumbnail

Opinion: Market share isn’t the only metric for biosimilars’ success

STAT

Market share is often held up as the most relevant metric for the success of a biosimilar class. I believe there are other metrics, like cost savings or signs of greater patient access, that should also be used to define biosimilars’ successes or failures. In the U.S., the first biosimilar was launched in September 2015. As I write this, there are 38 FDA-approved biosimilars ; 22 of them are commercially available.

FDA 75
article thumbnail

Mars, Lil Nas X unveil limited-edition M&M’s packs

Drug Store News

Each limited-edition pack blends pastel-colored blue, pink and purple lentils that feature Lil Nas X’s face, butterflies and heart graphics.

95
article thumbnail

STAT+: New details on Apple Watch study emphasize Medicaid enrollment

STAT

Newly published details about a high-profile Apple Watch study call it “a priority” to recruit Medicaid patients — a population not usually considered the target for Apple’s pricey products. In September 2020, health insurer Anthem, which is now called Elevance, announced a large study investigating whether an Apple Watch-based system could be used to help manage asthma.

article thumbnail

Coherus BioSciences to launch Lucentis biosimilar

Drug Store News

???????Cimerli is the first and only FDA-approved biosimilar interchangeable with Lucentis (ranibizumab injection).

FDA 97
article thumbnail

New Signify details, out-of-state telehealth use, and Fitbits to study brain exercise

STAT

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

76
article thumbnail

News Roundup: September 19 to September 23

Drug Topics

Your weekly roundup of the latest news from Drug Topics®.

98
article thumbnail

STAT+: Zuckerberg, Chan want new Harvard institute to answer questions about the brain and AI

STAT

For the first time since gifting Harvard University  $500 million to launch a new research institute , Mark Zuckerberg and Priscilla Chan visited the school Thursday to talk about their ambitious goal to study the basis of intelligence. The couple, who originally met at Harvard, were in Boston to celebrate the launch of the  Kempner Institute for the Study of Natural and Artificial Intelligence , which will focus on the brain and AI systems — and what scientists don’t kno

72
article thumbnail

AACR Progress Report Highlights New Drugs Along With Disparities, Challenges of Obesity, Aging Population

Pharmacy Times

The annual report notes that progress in reducing cancer mortality is uneven among populations, with minority groups not seeing the same benefits from therapeutic advances.

65
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right.   Send us your changes, and we’ll find a home for them.   Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

72
article thumbnail

24th Annual NACDS Foundation Dinner to feature astrophysicist Neil deGrasse Tyson

Drug Store News

The event will be held Nov. 30, 2022, at the Sheraton New York Times Square in New York City.

98
article thumbnail

Merck obtains favourable US court ruling on sitagliptin patent lawsuit

Pharmaceutical Technology

Merck (MSD outside of North America) has reported that it received a ruling in favour of the company from the US District Court for the Northern District of West Virginia in a patent infringement suit against Viatris linked to sitagliptin. Sitagliptin is an active ingredient in the Januvia, Janumet and Janumet XR therapies. The suit involved two Merck patents.

FDA 69
article thumbnail

Dollar General enters vitamin space with OhGood!

Drug Store News

Dollar General is debuting OhGood!, a health and wellness supplements line of 18 products.

98
article thumbnail

Enhancing Patient Engagement With Data, Insights and Digital Tools While Reducing Pharmacy Costs and Improving Outcomes

Pharmacy Times

Specialty pharmacies need processes, systems and tools to quickly determine medication delivery status, reassure confidence, and alleviate patient anxiety.

article thumbnail

Dollar General enters vitamin space with OhGood!

Drug Store News

Dollar General is debuting OhGood!, a health-and-wellness supplements line of 18 products.

98
article thumbnail

New Modeling System May Advance Care for Autosomal Recessive Polycystic Kidney Disease

Pharmacy Times

Innovative system reveals a pair of potential therapies for autosomal recessive polycystic kidney disease, which currently has no FDA-approved treatments.

FDA 65
article thumbnail

Notable products at NACDS Total Store Expo: Part 1

Drug Store News

DSN spent two days walking the hall and these are among some of the cool products found.

97
article thumbnail

Drug developers look at innovative mechanisms to tackle dry eye syndrome

Pharmaceutical Technology

Dry eye syndrome (DES) is an indication whose mainstay treatment has been dominated by Allergan’s Restasis (cyclosporine ophthalmic emulsion 0.05%) ever since its launch in 2003 in the US. While a handful of therapies have launched since then, late-stage pipeline therapies that are currently in development reveal that drug developers are exploring a broad set of mechanisms of action (MOAs), many of which are innovative, to tackle DES.

FDA 59